Experience of the Nationwide Gambling Self-exclusion Service Spelpaus - Effects and Limitations of a Unique Harm Reduction Instrument for Problem Gambling

Sponsor
Region Skane (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05693155
Collaborator
(none)
20
1
18
1.1

Study Details

Study Description

Brief Summary

Qualitative interview study addressing the effects and limitations of a unique, government-based, nationwide self-exclusion service for the reduction of gambling-related harm. This service, which allows for individuals at risk of gambling problems (and for anyone) to self-exclude from all licensed gambling in the country, is unique in its nationwide, non-gambling-operator-dependent and multi-operator design. It is a promising tool for the prevention and harm reduction in relation to problem gambling and gambling disorder, but emerging research data report considerable limitations including high access to non-licensed gambling allowing users to breach the voluntary self-exclusion and relapse into hazardous gambling practices. This study will examine effects and limitations of the system, for gamblers and for concerned significant others of gamblers, through qualitative interviews addressing their experience of the system.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Voluntary self-exclusion from gambling ('Spelpaus')

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Experience of the Nationwide Gambling Self-exclusion Service Spelpaus - Effects and Limitations of a Unique Harm Reduction Instrument for Problem Gambling
Anticipated Study Start Date :
Jan 30, 2023
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Jul 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Individuals with a gambling problem

Recruited from a gambling disorder treatment unit and/or from social media advertising addressing individuals with a gambling problem.

Behavioral: Voluntary self-exclusion from gambling ('Spelpaus')
Voluntary self-exclusion from gambling, using the government-based, official service 'Spelpaus' (literally 'play break')

Concerned significant others

Recruited as concerned signifiant others of patients at a gambling disorder treatment unit and/or in social media advertising addressing concerned significant others of individuals with a gambling problem.

Behavioral: Voluntary self-exclusion from gambling ('Spelpaus')
Voluntary self-exclusion from gambling, using the government-based, official service 'Spelpaus' (literally 'play break')

Outcome Measures

Primary Outcome Measures

  1. Qualitative reporting of self-perceived effects from self-exclusion [Since 2019]

    Subjective perception of favorable effects on gambling behavior or well-being

  2. Qualitative reporting of self-perceived harm or limitations from self-exclusion [Since 2019]

    Subjective perception of negative impact or lack of improvement with respect to gambling behavior or well-being

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Patient at a gambling disorder unit or self-recruited through social media advertising and defining as a person with a gambling problem, and/or concerned significant other of a patient at a gambling disorder unit or self-recruited through social media advertising and defining as a concerned significant other of a person with a gambling problem.
Exclusion Criteria:
  • Inability to provide informed study consent and to carry out a qualitative research interview, due to language difficulties and/or cognitive problems.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Malmö Addiction Center Malmö Sweden

Sponsors and Collaborators

  • Region Skane

Investigators

  • Principal Investigator: Anders Håkansson, PhD, Region Skåne

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anders C Håkansson, Consultant physician, professor, Region Skane
ClinicalTrials.gov Identifier:
NCT05693155
Other Study ID Numbers:
  • Spelpaus study
First Posted:
Jan 20, 2023
Last Update Posted:
Jan 20, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Anders C Håkansson, Consultant physician, professor, Region Skane
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 20, 2023